Related Content
November 20, 2013 — Neovasc Inc. reported the results from its COSIRA (coronary sinus reducer for treatment of ...
November 15, 2013 – Neovasc Inc. announced that the first patent covering the company's innovative Tiara transcatheter ...
May 24, 2013 — Neovasc Inc. reported positive animal data from its Tiara program for the transcatheter treatment of ...
September 18, 2012 — Neovasc Inc. announced that acute results from preclinical studies of its Tiara valve for the ...
December 15, 2011 — Neovasc Inc. announced it has received the CE mark designation for its Reducer product for the ...
August 19, 2011 - Neovasc Inc. accomplished $4.7 million in financing to complete the COSIRA clinical trial for the ...
May 19, 2011 - Neovasc Inc., a developer of novel technologies used to treat vascular disease, reported positive six ...
September 28, 2010 – The Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium featured a live case broadcast ...
September 21, 2010 – The first patients have been enrolled in a trial testing a new treatment for refractory angina. The ...
January 28, 2009 – Under the terms of a newly penned seven-year agreement, LeMaitre Vascular has earned exclusive rights ...